Saito, M.; Mori, A.; Ishio, T.; Kobayashi, M.; Tsukamoto, S.; Kajikawa, S.; Yokoyama, E.; Kanaya, M.; Izumiyama, K.; Muraki, H.;
et al. Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study. Viruses 2024, 16, 328.
https://doi.org/10.3390/v16030328
AMA Style
Saito M, Mori A, Ishio T, Kobayashi M, Tsukamoto S, Kajikawa S, Yokoyama E, Kanaya M, Izumiyama K, Muraki H,
et al. Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study. Viruses. 2024; 16(3):328.
https://doi.org/10.3390/v16030328
Chicago/Turabian Style
Saito, Makoto, Akio Mori, Takashi Ishio, Mirei Kobayashi, Shihori Tsukamoto, Sayaka Kajikawa, Emi Yokoyama, Minoru Kanaya, Koh Izumiyama, Haruna Muraki,
and et al. 2024. "Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study" Viruses 16, no. 3: 328.
https://doi.org/10.3390/v16030328
APA Style
Saito, M., Mori, A., Ishio, T., Kobayashi, M., Tsukamoto, S., Kajikawa, S., Yokoyama, E., Kanaya, M., Izumiyama, K., Muraki, H., Morioka, M., & Kondo, T.
(2024). Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study. Viruses, 16(3), 328.
https://doi.org/10.3390/v16030328
